Randomized phase II study of the neurokinin 1 receptor antagonist CJ- 11,974 in the control of cisplatin-induced emesis

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 338-343

  Hesketh, Paul J ^a   Gralla, R J ^a   Webb, R T ^a   Ueno, W ^a   DelPrete, S ^a   Bachinsky, M E ^a   Dirlam, N L ^a   Stack, C B ^a   Silberman, S L ^a  

^a PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DEXAMETHASONE; EZLOPITANT; GRANISETRON; NEUROKININ 1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; VOMITING;

EID: 0032951327     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.338     Document Type: Article

References (25)

1. Hesketh PJ, Gandara DR: Serotonin antagonists: A new class of antiemetic agents. J Natl Cancer Inst 83:613-620, 1991
2. Perez EA: Review of the preclinical pharmacology and comparative efficacy of 5-hydroxytryptamine-3 receptor antagonists for chemotherapy-induced emesis. J Clin Oncol 13:1036-1043, 1995
3. Morrow GR, Hickok JT, Rosenthal SN: Progress in reducing nausea and emesis: Comparisons of ondansetron (Zofran), granisetron (Kytril) and tropisetron (Navoban). Cancer 76:343-357, 1996
4. 3 receptor antagonists. Support Care Cancer 2:286-292, 1994
5. Hesketh PJ, Harvey WH, Beck TM, et al: A randomized, double-blind comparison of intravenous ondansetron alone and in combination with intravenous dexamethasone in the prevention of high-dose cisplatin-induced emesis. J Clin Oncol 12:596-600, 1994
6. Roila F: Control of acute cisplatin-induced emesis over repeat courses of chemotherapy. Oncology 53:65-72, 1996 (suppl 1)
7. Frakes LA, Brehm TL, Kosty MP, et al: An all oral antiemetic regimen for patients undergoing high-dose chemotherapy with peripheral blood stem transplant. Bone Marrow Transplant 20:473-478, 1997
8. Dockray GJ: Substance P and other tachykinins, in Walsh JH, Dockray GJ (eds): Gut Peptides: Biochemistry and Physiology. New York, NY, Raven, 1994, pp 401-415
9. Watson JW, Nagahisa A, Lucot JB, et al: The tachykinins and emesis: towards complete control, in Reynolds DJM, Andrews PLR, Davis CJ (eds): Serotonin and the Scientific Basis of Anti-emetic Therapy. Oxford, United Kingdom, Oxford Clinical Communications, 1995, pp 233-238
10. 1 receptor antagonists act centrally to inhibit emesis induced by the chemotherapeutic agent cisplatin in ferrets. Neuropharmacology 35:1121-1129, 1996
11. 1 tachykinin receptor antagonist CP-99,994 in antagonizing the acute and delayed emesis induced by cisplatin in the ferret. Br J Pharmacol 119:931-936, 1996
12. 1 receptor antagonist. Br J Pharmacol 116:3149-3157, 1995
13. 1 receptor antagonist CP-99,994 in ferrets. Eur J Pharmacol 249:R3-R4, 1993
14. 1 receptor. Br J Pharmacol 115:84-94, 1995
15. 1 receptor antagonist CP-99,994. Neuropharmacology 33:259-260, 1994
16. 1 receptor antagonist. J Natl Cancer Inst 89:817-818, 1997
17. Hesketh P: Management of cisplatin-induced delayed emesis. Oncology 53:73-77, 1996 (suppl)
18. Whitehead J: The Design and Analysis of Sequential Clinical Trials (ed 2). Chichester, United Kingdom, Ellis Horwood, 1992
19. Brunier H, Whitehead J: PEST: Planning and Evaluation of Sequential Trials, version 3.0: Operating Manual. Reading, United Kingdom: PEST Project, University of Reading, 1993
20. Whitehead J: On the bias of maximum likelihood estimation following a sequential test. Biometrika 73:573-581, 1996
21. Grunberg SM, Hesketh PJ: Control of chemotherapy-induced emesis. N Engl J Med 329:1790-1796, 1993
22. Clark RA, Gralla RJ: Delayed emesis: A dilemma in antiemetic control. Support Care Cancer 1:182-185, 1993
23. Kris MG, Pisters KMW, Hinkley L: Delayed emesis following anticancer chemotherapy. Support Care Cancer 2:297-300, 1994
24. Tavorath R, Hesketh PJ: Drug treatment of chemotherapy-induced delayed emesis. Drugs 52:639-648, 1996
25. Tonato M, Roila F, Del Favero A: Methodology of antiemetic trials: A review. Ann Oncol 2:107-114, 1991